nemtabrutinib formerly arq small molecule drug works reversible brutons tyrosine kinase btk inhibitor unlike btk inhibitors also works mutated forms merck paid billion acquire company arqule drug investigated cancer httpsenwikipediaorgwikinemtabrutinib